Hyaluronic acid Completed Phase 2 Trials for Keratoconjunctival Epithelial Disorder Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01493180Exploratory Study of OPC-12759 Ophthalmic Suspension